Steroids and nitric oxide in sepsis

Area of Science:

• Physiology
• Endocrinology
• Immunology

Background:

• Nitric oxide (NO) production is implicated in the pathophysiology of sepsis and septic shock.
• Glucocorticoids are key players in the host's response to stress, including sepsis.
• Past studies led to a ban on steroid use in sepsis due to harmful effects of high doses.

Purpose of the Study:

• To review the intricate relationship among nitric oxide (NO), sepsis, and steroid hormones, particularly glucocorticoids.
• To highlight recent findings on adrenal insufficiency in sepsis and the potential benefits of low-dose cortisol therapy.
• To identify knowledge gaps and unanswered questions for improved sepsis and septic shock treatment.

Main Methods:

• Literature review focusing on the interplay of NO, steroids, and sepsis.
• Analysis of studies investigating glucocorticoid use in sepsis and septic shock.
• Synthesis of current understanding regarding the role of NO in sepsis pathophysiology.

Main Results:

• Nitric oxide (NO) has both detrimental and beneficial effects in sepsis.
• Adrenal insufficiency is increasingly recognized in sepsis patients.
• Low-dose, long-term cortisol treatment shows potential benefits in sepsis and septic shock.

Conclusions:

• The relationship between NO, steroids, and sepsis is complex and not fully understood.
• Further research is needed to clarify the precise roles and optimal therapeutic strategies.
• Understanding these interactions may lead to novel therapeutic alternatives for sepsis and septic shock.